Generac Holdings Set to Join S&P MidCap 400; Alexander & Baldwin and America's Car-Mart to Join S&P SmallCap 600 PR Newswire NEW YORK, Feb. 7, 2020 NEW YORK, Feb. 7, 2020 /PRNewswire/...
SHAREHOLDER ALERT: WeissLaw LLP Investigates Diplomat Pharmacy, Inc. PR Newswire NEW YORK, Dec. 12, 2019 NEW YORK, Dec. 12, 2019 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of...
Diplomat Announces 3rd Quarter Financial Results; Updates 2019 Guidance 3rd Quarter Revenue of $1,301 Million, compared to $1,373 Million, Net Loss of $177 Million, compared to Net Income of $0.2...
Diplomat to Release Third-Quarter 2019 Operating Results Nov. 12 PR Newswire FLINT, Mich., Oct. 30, 2019 FLINT, Mich., Oct. 30, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) will...
Diplomat Announces Sale of Certain Assets of Envoy Health Management, LLC to Diligent Health Solutions, LLC The nation's largest independent provider of specialty pharmacy services sells certain...
Diplomat Announces Promotion of David Skomo to Chief Operating Officer of CastiaRx Following the retirement of Chris Luthin, David Skomo Appointed COO at CastiaRx. PR Newswire FLINT, Mich., Oct...
Diplomat Announces 2nd Quarter Financial Results; Updates 2019 Guidance 2nd Quarter Revenue of $1,288 Million, compared to $1,416 Million, Net Loss of $159.5 Million, compared to a Net Loss of...
Diplomat Announces Review of Strategic Alternatives PR Newswire FLINT, Mich., Aug. 9, 2019 FLINT, Mich., Aug. 9, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) today announced that its...
Diplomat signs exclusive practice-based infusion agreement with Allergy Partners This innovative agreement forms the nation's first large-scale physician practice-based infusion program. PR...
Diplomat to Release Second-Quarter 2019 Operating Results August 9 PR Newswire FLINT, Mich., July 18, 2019 FLINT, Mich., July 18, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), will...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales